Medisan(SZ:002900) Zheng Quan Zhi Xing·2025-05-21 10:12Core Viewpoint - Harbin Sanlian Pharmaceutical Co., Ltd. has announced its 2024 annual profit distribution plan, which includes a cash dividend of 2.00 RMB per 10 shares for all shareholders, approved at the shareholders' meeting on May 15, 2025 [1]. Summary by Sections Profit Distribution Plan - The company will distribute a cash dividend of 2.00 RMB (including tax) for every 10 shares held, with an estimated total cash dividend amount subject to change due to factors like convertible bonds, share buybacks, and new shares from refinancing [1]. - The total share capital as of now is 316,357,550 shares, and the profit distribution ratio remains unchanged [1]. Dividend Taxation - For QFII, RQFII, and individual investors holding pre-IPO restricted shares, the cash dividend will be 1.80 RMB per 10 shares after tax. Different tax rates apply for various categories of shareholders, with the company not withholding individual income tax at this stage [1][2]. Key Dates - The record date for the dividend distribution is set for May 28, 2025, and the ex-dividend date is May 29, 2025 [1]. Distribution Method - Cash dividends will be directly credited to shareholders' accounts through their securities companies or other custodians on the ex-dividend date [1]. Adjustment of Parameters - Following the dividend distribution, the repurchase price for unvested restricted stock under the 2022 incentive plan will be adjusted from 6.68 RMB per share to 6.48 RMB per share [2].